Myocyte Enhancer Factor 2 Acetylation by p300 Enhances Its DNA Binding Activity, Transcriptional Activity, and Myogenic Differentiation

ABSTRACT Myocyte enhancer factor 2 (MEF2) family proteins are key transcription factors controlling gene expression in myocytes, lymphocytes, and neurons. MEF2 proteins are known to be regulated by phosphorylation. We now provide evidence showing that MEF2C is acetylated by p300 both in vitro and in vivo. In C2C12 myogenic cells, MEF2 is preferentially acetylated in differentiating myocytes but not in undifferentiated myoblasts. Several major acetylation sites are mapped to the transactivation domain of MEF2C, some of which are fully conserved in other MEF2 members from several different species. Mutation of these lysines affects MEF2 DNA binding and transcriptional activity, as well as its synergistic effect with myogenin in myogenic conversion assays. When introduced into C2C12 myoblasts, the nonacetylatable MEF2C inhibits myogenic differentiation. Thus, in addition to phosphorylation, MEF2 activity is also critically regulated by acetylation during myogenesis.

[1]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[2]  B. Kirschbaum,et al.  A Novel Complex Regulates cardiac actin Gene Expression through Interaction of Emb, a Class VI POU Domain Protein, MEF2D, and the Histone Transacetylase p300 , 2004, Molecular and Cellular Biology.

[3]  Zhenguo Wu,et al.  Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation , 2004, Journal of Cell Science.

[4]  L. Kedes,et al.  Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C , 1997, Molecular and cellular biology.

[5]  A. Harel-Bellan,et al.  Acetylation of MyoD by p300 Requires More Than Its Histone Acetyltransferase Domain* , 2001, The Journal of Biological Chemistry.

[6]  L. Kedes,et al.  Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. , 1997, Molecular cell.

[7]  E. Topol,et al.  Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease , 2003, Science.

[8]  R A Schulz,et al.  Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila , 1995, Science.

[9]  L. Kedes,et al.  Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. , 1999, Molecular cell.

[10]  A. Lassar,et al.  Inhibition of Myogenic bHLH and MEF2 Transcription Factors by the bHLH Protein Twist , 1996, Science.

[11]  Po Zhao,et al.  Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. , 2003, Molecular cell.

[12]  C. Bucana,et al.  Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. , 1997, Science.

[13]  E. Olson,et al.  FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains , 1992, Cell.

[14]  Jonas Wittwer,et al.  Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5 , 2003, The EMBO journal.

[15]  Chun Li Zhang,et al.  Signaling chromatin to make muscle. , 2002, Current opinion in cell biology.

[16]  Jiahuai Han,et al.  Regulation of the MEF2 Family of Transcription Factors by p38 , 1999, Molecular and Cellular Biology.

[17]  E. Olson,et al.  Control of muscle development by dueling HATs and HDACs. , 2001, Current opinion in genetics & development.

[18]  C. Allis,et al.  Roles of histone acetyltransferases and deacetylases in gene regulation , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[19]  G. Zhu,et al.  Functional Characterization of an Amino-terminal Region of HDAC4 That Possesses MEF2 Binding and Transcriptional Repressive Activity* , 2003, Journal of Biological Chemistry.

[20]  R. Schiltz,et al.  A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program , 2001, The EMBO journal.

[21]  B. Nadal-Ginard,et al.  A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. , 1993, Development.

[22]  E. Olson,et al.  Separable regulatory elements governing myogenin transcription in mouse embryogenesis. , 1993, Science.

[23]  B. Black,et al.  Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor , 2002, Nature Medicine.

[24]  B. Black,et al.  Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. , 1998, Annual review of cell and developmental biology.

[25]  H. Youn,et al.  Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. , 1999, Science.

[26]  Qing Xu,et al.  The Insulin-like Growth Factor-Phosphatidylinositol 3-Kinase-Akt Signaling Pathway Regulates Myogenin Expression in Normal Myogenic Cells but Not in Rhabdomyosarcoma-derived RD Cells* , 2000, The Journal of Biological Chemistry.

[27]  M. Goebl,et al.  Phosphorylation of Nuclear MyoD Is Required for Its Rapid Degradation , 1998, Molecular and Cellular Biology.

[28]  B. Black,et al.  Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins , 1995, Cell.

[29]  M E Greenberg,et al.  Neuronal activity-dependent cell survival mediated by transcription factor MEF2. , 1999, Science.

[30]  P. Rigby,et al.  The regulation of myogenin gene expression during the embryonic development of the mouse. , 1993, Genes & development.

[31]  B. Wold,et al.  Skeletal muscle determination and differentiation: story of a core regulatory network and its context. , 1996, Current opinion in cell biology.

[32]  E. Olson,et al.  Defining the regulatory networks for muscle development. , 1996, Current opinion in genetics & development.

[33]  Wei Gu,et al.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. , 2003, Current opinion in cell biology.

[34]  A. Ciechanover,et al.  A novel site for ubiquitination: the N‐terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein , 1998, The EMBO journal.

[35]  R. W. Lee,et al.  Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. , 1992, Molecular biology of the cell.

[36]  Jiahuai Han,et al.  BMK1/ERK5 regulates serum‐induced early gene expression through transcription factor MEF2C , 1997, The EMBO journal.

[37]  Jiahuai Han,et al.  Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation , 1997, Nature.

[38]  Zhenguo Wu,et al.  p38 and Extracellular Signal-Regulated Kinases Regulate the Myogenic Program at Multiple Steps , 2000, Molecular and Cellular Biology.

[39]  H. Arnold,et al.  The myogenin gene is activated during myocyte differentiation by pre-existing, not newly synthesized transcription factor MEF-2. , 1994, The Journal of biological chemistry.

[40]  A. Giordano,et al.  p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription , 1997, The EMBO journal.

[41]  Jiing-Dwan Lee,et al.  Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. , 2004, The Journal of clinical investigation.

[42]  J B Lawrence,et al.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.